Ads
related to: breast cancer cell receptors- Patient Assistance Tool
Find Financial Support Options
For A NTRK+ Gene Fusion Cancer.
- NTRK+ Gene Fusion Testing
Find More Info About Testing For
The NTRK+ Gene.
- Patient Assistance Tool
Search results
Drug resistance discovery could 'move the field forward' for breast cancer treatment
Medical Xpress· 19 hours agoAdditionally, the research team tested a promising drug in combination with an existing therapy that...
Breast Cancer in Young Women: Rates Rise, Guidelines Shift
WebMD· 1 day agoBreast cancer does not discriminate based on age. Women across the world are increasingly becoming diagnosed with breast cancer ...
Innovations in Breast Cancer Diagnosis and Treatment
New Jersey Business Magazine· 20 hours agoAlthough New Jersey is often ranked among the top 10 states in the nation for breast cancer incidence and mortality, the state’s healthcare institutions...
Advanced breast cancer increases linked to screening in COVID-19 pandemic
Cosmos· 1 day agoCOVID-19 brought an unprecedented shift in the approach to breast cancer screening and treatment in...
Inhibition of lysosomal TRPML1 channel eliminates breast cancer stem cells by triggering ferroptosis...
Nature· 3 days agoHere, we show that the lysosomal cation channel TRPML1 represents a promising target for CSCs. TRPML1 is highly expressed in breast cancer cells and exhibits ...
Luton man treated for breast cancer given 'wonder drug'
BBC News· 3 days agoA man who was given "a wonder drug" to target his stage four cancer said it was "like an oasis in...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 3 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
... for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer...
NBC 10 - FOX 14 Monroe· 7 days agoThe data, which mark the first promising clinical results for a CDK2 inhibitor in combination with an approved CDK4/6 inhibitor, will be presented at the 2024 American Society of Clinical ..
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks via Yahoo Finance· 6 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days ago- New Positive Phase 2 Results in Metastatic Triple Negative Breast Cancer (mTNBC) Indicate That Use of Trilaciclib in Combination with a TROP2 ADC May ...
Ads
related to: breast cancer cell receptors